HealthCare Market Analysis

The global  orthopedic navigation system market  is expected to reach USD 303.7 million by 2025, according to a new study by Grand View Research, Inc. Increasing geriatric population prone to orthopedic diseases is a key contributing factor propelling the demand for orthopedic navigation systems over the forecast period. Osteoarthritis and osteoporosis are most common disorders in the population aged 70 years and above. Growing prevalence of these disorders results in increased economic burden on many countries. According to the WHO, 9.6% of men and 18% of women are suffering from various forms of arthritis globally. Over 82% of people suffering from osteoarthritis have difficulty in movement and around 25% are not able to perform daily activities. Degenerative joint disorders affect majorly knee, hip, and ankle. Knee and hip replacement procedures are performed in 85% of patients suffering from osteoarthritis. Other factors include physical inactivity, obesity, unhealthy lifesty

The global  Single Cell analysis market  is expected to reach USD 5.0 billion by 2024, according to a new report published by Grand View Research, Inc. The rising adoption of Single Cell analysis tools owing to the improving healthcare scenario is fueling the growth of the market. The continuous efforts in the R&D sector of the healthcare industry are resulting in the wide applicability of the Single Cell analysis technologies in the different disease areas, as a widespread diagnostic tool to address the complex heterogeneity observed in cells. Introduction of stem cell therapies and non-invasive techniques for prenatal analysis are some of the examples of the applications of the Single Cell analysis techniques. On the contrary, the high-cost and long shelf-life of the instruments is challenging the growth of the market. In addition, the increasing pool of individuals suffering from target diseases, such as cancer, and neurological disorders, rising per capita income, and

Global  Small Animal Imaging (In-Vivo) market  is expected to reach USD 2.7 billion by 2022, according to a new study by Grand View Research, Inc. Growing number of medical conditions requiring accurate research for development of treatment options is expected to enhance demand for small animal imaging (in-Vivo) over the forecast period. Importance of these devices in applications such as epigenetic research studies, drug receptor targeting, and defining mechanism of action is estimated to provide potential growth platform for this industry. The major factors driving the growth of small animal imaging (in-vivo) market are growing usage of multi-functional pre-clinical imaging, rising investments of CROs in pre-clinical studies, increasing number of pharmaceutical and research organizations and technical innovations such as high-resolution MRI with other modalities. Browse full research report on Small Animal Imaging Market: http://www.grandviewresearch.com/industry-analysis/smal

Global  Smart Healthcare Market  is expected to reach USD 225.54 Billion by 2022, according to a new study by Grand View Research, Inc. Rapid technological advancements in healthcare IT is expected to remain a key driving factor of the global smart healthcare market over the forecast period.  Growing implementation of inventory management systems such as RFID KanBan and RFID smart cabinets aimed at curbing inventory costs and ensure appropriate logistics management is expected to boost the growth of the smart healthcare market. Development of smart syringes, smart pills and smart bandages which enable remote monitoring of patients, help in diagnosing gastrointestinal diseases and infection spread minimization and remote monitoring of healing processes is expected to strengthen the platform for future market growth. On the other hand, high capital investments and poor awareness levels among consumers are some challenges faced by manufacturers. mHealth is expected to register t

The global  medical device outsourcing market  is expected to reach USD 88.2 billion by 2025, according to a new report by Grand View Research, Inc. Rising price competition and rising need for reduction of production cost are the most impact rendering driver of the medical device outsourcing market. Sharp cutbacks in the public spending in major EU regions and the U.S., is the major issue currently faced by medical devices manufacturers. Increasing profitability pressure and growing competition coupled with high degree of industry maturity is expected to impact growth. The medical device outsourcing market is dynamic and highly competitive. Over the next seven years, the industry is expected to witness significant growth owing to steep decline in duration for product commercialization by companies in order to gain the advantage of being the first mover. Product design and development services are anticipated to be one of the highly availed services by device manufacturers

The global  legionella testing market  is expected to reach USD 352.6 million by 2025, according to a new study by Grand View Research Inc. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected to drive the industry growth. According to CDC, the number of people suffering from Legionnaires’ disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due the contaminated environment. The rising incidence of Legionellosis will drive the market growth in the coming years, especially in the industrial sector. The conventional bacterial testing is least preferred nowadays, since it is labor intensive and time consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry. Browse full research report on Legionella Testing Market: http://www.grandviewresearch.com/industry-analysis/l

The global  vaccine market  is expected to reach over USD 77.5 billion by 2024, according to a new report by Grand View Research, Inc. The presence of numerous molecules in the pipeline is anticipated to meet the demand for efficient vaccines. These include vaccines for chest infection, tuberculosis, malaria, and dengue. Most of the key players are actively leveraging on their vaccine development technologies to launch novel preventative solutions with an objective to increase their market share. For instance, Pfizer, Inc. is involved in the development of vaccines to prevent severe infections caused by Meningococcal B,  Clostridium difficile , and  Staphylococcus aureus .  Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with high morbidity and mortality is expected to stimulate the market

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultras

The global   tuberculosis diagnostics market  is expected to reach USD 3.1 billion by 2024, according to a new report by Grand View Research, Inc. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB. These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavors directed toward containing the incidence of this infectious disease. The inc

The global  surgical equipment market  is anticipated to reach a value of USD 20.3 billion by 2025, according to a new report by Grand View Research, Inc. The rapidly escalating number of minimally invasive surgical procedures throughout the world is expected to support market growth. Chronic diseases are one of the major leading causes of surgeries at a global level. Increasing prevalence of chronic diseases, such as neurological and cardiovascular disorders, is affecting the society to a great extent. As a result of which, the number of surgeries is increasing. This is mainly due to the fact that surgery is the primary treatment for people suffering from such disorders. In addition, minimally invasive surgeries are also trending as treatment for heart diseases. Road and other accidents are also expected to drive the surgical instruments market over the forecast period. This is due to the fact that accidents might lead to severe injuries. As a result of which, wound closure

The global  therapeutic drug monitoring market  is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth. The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administere